Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh

Tropical Medicine and International Health

Volumn 9, Issue 6, 2004, Pages 680-687

  Van Den Broek, Ingrid V F ^a   Van Der Wardt, Sophia ^a   Talukder, Lenin ^a   Chakma, Swarupa ^a   Brockman, Alan ^b   Nair, Shalini ^c   Anderson, Tim C ^c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Drug efficacy; Genotyping; Malaria; Quinine; Sulphadoxine pyrimethamine

Indexed keywords

CHLOROQUINE; MOLECULAR MARKER; PYRIMETHAMINE; SULFADOXINE;

DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; QUININE;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; INFECTION RATE; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEDICAL ASSESSMENT; MUTATION RATE; PARASITEMIA; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; BANGLADESH; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; MUTATION; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; PYRIMETHAMINE; QUININE; SULFADOXINE; TREATMENT OUTCOME;

ASIA; BANGLADESH; CHITTAGONG [BANGLADESH]; EURASIA; SOUTH ASIA;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 3042644635     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01249.x     Document Type: Article

References (30)

1. Anderson TJ, Nair S, Jacobzone C, Zavai A & Balkan S (2003) Molecular assessment of drug resistance in P. falciparum from Bahr El Gazal Province, Sudan. Tropical Medicine and International Health 8, 1068-1073.
2. Berens N, Schwoebel B, Jordan S et al. (2003) Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR. Tropical Medicine and International Health 8, 775.
3. Brockman A, Paul R, Anderson T et al. (1999) Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. American Journal of Tropical Medicine and Hygiene 60, 14-21.
4. Djimde A, Doumbo OK, Steketee RW & Plowe CV (2001) Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358, 890-891.
5. Fidock DA, Nomura T, Talley AK et al. (2000) Mutations in the P. falciparum digestive vacuole trans-membrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell 6, 861-871.
6. Foote SJ, Kyle DE, Martin RK et al. (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345, 255-258.
7. Jelinek T, Aida AO, Peyerl-Hoffmann G et al. (2002) Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania. American Journal of Tropical Medicine and Hygiene 67, 449-453.
8. Kublin JG, Dzinjalamala FK, Kamwendo DD et al. (2002) Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases 185, 380-388.
9. Labbe AC, Bualombai P, Pillai DR et al. (2001) Molecular markers for chloroquine-resistant Plasmodium falciparum malaria in Thailand and Laos. Annals of Tropical Medicine and Parasitology 95, 781-788.
10. Mabuza A, Govere J, Durrheim D et al. (2001) Therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria 3 years after introduction in Mpumalanga. South African Medical Journal 91, 975-978.
11. Mendez F, Munoz A, Carasquilla G et al. (2002) Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. American Journal of Epidemiology 156, 230-238.
12. Montanari RM, Bangali AM, Talukder KR et al. (2001) Three case definitions of malaria and their effect on diagnosis, treatment and surveillance in Cox's Bazar district, Bangladesh. Bulletin of the World Health Organisation 79, 648-656.
13. Nair S, Brockman A, Paiphun L, Nosten F & Anderson TJ (2002) Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. International Journal of Parasitology 32, 852-858.
14. Nair S, Williams JT, Brockman A et al. (2003) A selective sweep driven by pyrimethamine treatment in SE Asian malaria parasites. Molecular Biology and Evolution 20, 1526-1536.
15. Ngo T, Duraisingh M, Reed M, Hipgrave D, Biggs B & Cowman AF (2003) Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. American Journal of Tropical Medicine and Hygiene 68, 350-356.
16. Noedl H, Faiz MA, Yunus EB et al. (2003) Drug-resistant malaria in Bangladesh: an in vitro assessment. American Journal of Tropical Medicine and Hygiene 68, 140-142.
17. Nosten F, van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297-302.
18. Pickard AL, Wongsrichanalai C, Purfield A et al. (2003) Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrobial Agents and Chemotherapy 47, 2418-2423.
19. Plowe CV, Kublin JG & Doumbo OK (1998) P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resistance Updates 1, 389-396.
20. Price RN, Nosten F, Luxemburger C et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-1658.
21. Rahman MR, Faiz MA, Yunus EB, Mujibul Hoq AJM & Chowdhury MK (1996) Malaria: new clinical case definitions and treatment guidelines. Journal of the Chittagong Medical College Training Association 7, 75-82.
22. Rahman MR, Hassan MR, Faiz MA, Paul B & Jalil MA (1998) Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar. Bangladesh Medical Research Council Bulletin 24, 67-74.
23. Rahman MR, Paul DC, Rashid M et al. (2001) A randomised controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh - narrowing the options for the National Malaria Control Programme? Transactions of the Royal Society of Tropical Medicine 95, 661-667.
24. Rosenberg R (1982) Forest malaria in Bangladesh. III. Breeding habits of Anopheles dirus. American Journal of Tropical Medicine and Hygiene 31, 192-201.
25. von Seidlein L, Drakeley C, Greenwood B, Walraven G & Targett G (2001) Risk factors for gametocyte carriage in Gambian children. American Journal of Tropical Medicine and Hygiene 65, 523-527.
26. Smithuis FM, Moni F, Grundl M et al. (1997) Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Transactions of the Royal Society of Tropical Medicine 91, 468-472.
27. White NJ (1998) Preventing antimalarial drug resistance through combinations. Drug Resistance Update 1, 3-9.
28. White NJ, Nosten F, Looareesuwan S et al. (1999) Averting a malaria disaster. Lancet 353, 1965-1967.
29. WHO (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO, Geneva. WHO/MAL/96.1 077.
30. WHO (2002) Monitoring antimalarial drug resistance. WHO, Geneva. WHO/CDS/RBM/2003.39.